BX-1

DRUG2 trials

Sponsors

Bionorica SE, Charite University, Berlin, Germany

Conditions

Posttraumatic Stress DisorderSpasticity Due to Multiple Sclerosis

Phase 2

Treating Nightmares in Posttraumatic Stress Disorder With Dronabinol

CompletedNCT04448808

Charite University, Berlin, GermanyPosttraumatic Stress Disorder

Start: 2020-10-01End: 2025-01-02Updated: 2025-08-13

Phase 3

BX-1 in Spasticity Due to Multiple Sclerosis

CompletedNCT03756974

Bionorica SESpasticity Due to Multiple Sclerosis

Start: 2019-02-18End: 2021-03-30Updated: 2021-05-05

Related Papers

Dronabinol for nightmares in post-traumatic stress disorder: a randomized controlled trial.

2026-08-05

Treating nightmares in posttraumatic stress disorder with dronabinol: study protocol of a multicenter randomized controlled study (THC PTSD-trial).

2023-05-055 citations